RELAPSING MULTIPLE SCLEROSIS
EMD SERONO
A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared with Aubagio, in Participants with Relapsing Multiple Sclerosis to Evaluate Efficacy and Safety.
EMD SERONO
A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared with Aubagio, in Participants with Relapsing Multiple Sclerosis to Evaluate Efficacy and Safety.
